Harvett,
Once again you have (deliberately?) distorted the truth.
You state that "Even a placebo with carboplatin added at AUC2 proceduced (sic) a median PFS of 20 weeks. And we are suppose to applaud for 12 weeks." What you failed to say was that carboplatin at AUC=2 in this case was administered WEEKLY.
This was equivalent to AUC=8 monthly, twice the dose used with NOX66. I'm sure you will respond with some irrelevant data that suits your purpose, but I do not care.
The great pity is that your vendetta has no doubt turned some investors off Noxopharm and thus deprived them of a windfall gain. Well done.
ESMO Presentation, page-19
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 33757 | 2 |
View Market Depth
| Last trade - 11.55am 08/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable